2025006564 - Fremanezumab 225 mg/1.5 ml Sol inj Caneta 1.5

ID 11658018 · Portal BASE
Price
Base Price
€4,821 .00
Effective Price
€4,821 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33661700
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
TEVA PHARMA - PRODUTOS FARMACÊUTICOS LDA
NIF 507045491
Company
Dates
Publication
26 Aug 2025
Celebration
07 Aug 2025
Contracting Entity
ESTADO-MAIOR-GENERAL DAS FORÇAS ARMADAS
NIF 600010180
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 75 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
26 Aug 2025
Signing Date
07 Aug 2025
Days Late
19
Rule
A2/A3 late publication: 19 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
4821.0
Threshold
5000.0
Rule
A5 threshold splitting: price within 5% below 5000.0
Detected 2026-03-06